SABBY MANAGEMENT, LLC - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 37 filers reported holding UNUM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$133,000
-85.3%
50,922
-75.3%
0.17%
-61.6%
Q1 2019$906,000
-53.9%
206,358
-53.8%
0.44%
+0.5%
Q4 2018$1,966,000
-64.7%
446,814
-17.5%
0.43%
-39.4%
Q3 2018$5,577,000
-33.1%
541,420
-6.9%
0.71%
-44.6%
Q2 2018$8,342,000
-32.1%
581,303
-47.5%
1.29%
+75.6%
Q1 2018$12,292,0001,106,4450.73%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$14,757,00013.86%
New Leaf Venture Partners, L.L.C. 1,795,545$7,882,0002.16%
SECTORAL ASSET MANAGEMENT INC 1,587,437$6,969,0000.84%
SABBY MANAGEMENT, LLC 206,358$906,0000.44%
COWEN INC. 817,395$3,588,0000.38%
Novo Holdings A/S 473,441$2,078,0000.31%
PLATINUM INVESTMENT MANAGEMENT LTD 260,595$1,144,0000.03%
WASATCH ADVISORS LP 254,449$1,117,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 109,075$479,0000.01%
FIL Ltd 783,423$3,439,0000.01%
View complete list of UNUM THERAPEUTICS INC shareholders